TORONTO, Nov. 30, 2015 /CNW/ - On November 27, 2015, James Eaton, Chairman of Syncordia Technologies and Healthcare Solutions, Corp. ("Syncordia" or the "Company"), acquired ownership and control over 400,000 common shares of Syncordia (the "Common Shares") through the facilities of the TSX Venture Exchange at a price of $0.35 per Common Share.
Prior to the above-noted acquisitions, Mr. Eaton owned, directly or indirectly, 1,236,875 common shares of Syncordia (representing 6.3% of the issued and outstanding common shares of the Company) and warrants to purchase 401,250 common shares of the Company. Assuming the exercise of such warrants in full, Mr. Eaton beneficially owned, directly or indirectly, an aggregate of 1,638,125 common shares of the Company (representing approximately 8.2% of the issued and outstanding common shares of the Company) prior to the above-noted acquisitions. Mr. Eaton also holds 266,875 unvested options to acquire an additional 266,875 common shares of the Company.
After giving effect to the above-noted acquisitions, Mr. Eaton owns, directly or indirectly, an aggregate of 1,636,875 common shares of the Company, representing approximately 8.3% of the issued and outstanding common shares of the Company. Assuming the exercise of Mr. Eaton's warrants in full, Mr. Eaton owns, directly or indirectly, an aggregate of 2,038,125 common shares of the Company, representing approximately 10.2% of the issued and outstanding common shares of the Company.
Mr. Eaton purchased the Common Shares for investment purposes and has no present intention to acquire or dispose of additional securities of Syncordia, but may choose to do so from time to time in compliance with applicable laws.
This news release is being issued pursuant to National Instrument 62-103 The Early Warning System and Related Take-Over Bid and Insider Reporting Issues of the Canadian Securities Administrators. A copy of the report filed by Mr. Eaton in connection with the shares purchased is available on the Company's SEDAR profile or by contacting Nicholas Badder, Director of Corporate Development and Investor Relations of Syncordia at (647) 350-7962
SOURCE James Eaton
For further information: James Eaton, 2 Bloor Street West, Suite 2602, Toronto, ON M4W 3E2
Share this article